Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Pancréas
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A prospective, multicenter, randomized, double-blind, placebo-controlled, 2-parallel group, phase III study to compare efficacy and safety of masitinib 9 mg/kg/day in combination with gemcitabine compared to placebo in combination with gemcitabine in treatment of patients with advanced/metastatic pancreatic cancer.
Scientific Abstract
en cours d'intégration;